PolyPeptide Group AG (PPGN.SW)
PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally.
43.95+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+94.0%
The outlook
PolyPeptide Group AG currently reads as leaning bullish based on buy — 2.0 avg of 6 analysts, above its 50- & 200-day averages, 80% of the way from its 52-week low to high, avg target -12% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 6 analysts
Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Price targetAvg target -12% vs current price
Analyst price target
~12-month · 6 analysts38.89average target-11.5% vs now
Now 43.95
Low 25.76High 45.38
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.45B
52-wk high
50.10
52-wk low
20.10
50-day avg
41.45
200-day avg
31.28
Trailing P/E
—